Best Form 483 response support: 7 Clear, Defensible steps for inspection-ready CAPA
Form 483 response support turns observations into CAPA with verifiable effectiveness and fast retrieval. Reduce follow-up risk and regain control. Ask for a quick estimate.
Best first FDA inspection readiness: 10 Practical, Defensible steps for biotech founders
First FDA inspection readiness keeps evidence retrievable across SOPs, data, and vendors. Reduce surprises and move faster. Request a scoping call.
From Preclinical Data to IND Filing: BioBoston’s Strategic Approach to Drug Development Success
The journey from preclinical research to an Investigational New Drug (IND) filing marks a pivotal phase in drug development. For biotech startups and pharmaceutical innovators, this stage determines whether a promising molecule can advance into clinical testing. However, navigating regulatory complexities, data integration, and FDA submission requirements can be overwhelming without the right strategy. At […]